Search

everythinglearnresearchcommunity

for

Search:↓

Taiwanese women with PCOS experience different symptoms based on age, with younger women facing more hormone imbalances and older women dealing with more metabolic issues.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Hair loss may indicate higher heart risk and metabolic issues.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Tirzepatide may improve hair loss by reducing insulin resistance.

The Chi-PCOSQ is effective for assessing health-related quality of life in Chinese women with PCOS.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

New treatments for PCOS focus on managing symptoms and improving fertility.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

PCOS is a long-term condition that needs more research for better understanding and treatment.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

PCOS is a major cause of infertility and requires personalized treatment.

Children with classic congenital adrenal hyperplasia have thicker heart fat and are at higher risk for heart problems and early atherosclerosis.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Combining spironolactone with metformin reduces insulin resistance in PCOS better than either drug alone.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

PCOS causes hormonal imbalances, irregular periods, and can lead to infertility, obesity, and mental health issues.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

The genetic variant studied does not affect PCOS symptoms in Kashmiri women.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

PCOS may increase the risk of high blood pressure and heart issues.

Women with PCOS may have a higher risk of Alzheimer's disease.